LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 7.06 | 27.76 | 1023 | 360 | 2.8417 | 1.6529 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 8.76 | 27.76 | 1 | 401 | 0.0025 | -0.5779 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 8.76 | 27.76 | 688 | 401 | 1.7151 | 1.3006 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 8.76 | 27.76 | 7 | 401 | 0.0175 | -0.3006 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 8.76 | 27.76 | 1097 | 401 | 2.7347 | 1.5967 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 10.46 | 27.76 | 3 | 438 | 0.0068 | -0.4281 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 10.46 | 27.76 | 734 | 438 | 1.6733 | 1.2760 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 10.46 | 27.76 | 6 | 438 | 0.0137 | -0.3193 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 10.46 | 27.76 | 1108 | 438 | 2.5260 | 1.5240 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 12.17 | 27.76 | 3 | 489 | 0.0061 | -0.4158 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 12.17 | 27.76 | 769 | 489 | 1.5724 | 1.2311 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 12.17 | 27.76 | 15 | 489 | 0.0307 | -0.1382 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 12.17 | 27.76 | 1191 | 489 | 2.4352 | 1.4798 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 13.87 | 27.76 | 90 | 604 | 0.1488 | 0.3029 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 13.87 | 27.76 | 768 | 604 | 1.2700 | 1.1105 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 13.87 | 27.76 | 19 | 604 | 0.0314 | -0.0817 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 13.87 | 27.76 | 1184 | 604 | 1.9579 | 1.3263 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 15.58 | 27.76 | 188 | 685 | 0.2742 | 0.5121 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 15.58 | 27.76 | 807 | 685 | 1.1771 | 1.0718 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 15.58 | 27.76 | 25 | 685 | 0.0365 | -0.0224 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 15.58 | 27.76 | 1221 | 685 | 1.7810 | 1.2658 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 17.28 | 27.76 | 515 | 838 | 0.6140 | 0.8112 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 17.28 | 27.76 | 779 | 838 | 0.9288 | 0.9702 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 17.28 | 27.76 | 39 | 838 | 0.0465 | 0.0716 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 17.28 | 27.76 | 1222 | 838 | 1.4570 | 1.1591 | MN20160318_Q01 | L22 |